Literature DB >> 26577585

Insulin augments serotonin-induced contraction via activation of the IR/PI3K/PDK1 pathway in the rat carotid artery.

Shun Watanabe1, Takayuki Matsumoto1, Mirai Oda1, Kosuke Yamada1, Junya Takagi1, Kumiko Taguchi1, Tsuneo Kobayashi2.   

Abstract

Hyperinsulinemia associated with type 2 diabetes may contribute to the development of vascular diseases. Although we recently reported that enhanced contractile responses to serotonin (5-hydroxytryptamine, 5-HT) are observed in the arteries of type 2 diabetes models, the causative factors and detailed signaling pathways involved remain unclear. The purpose of this study was to investigate whether high insulin would be an amplifier of 5-HT-induced contraction in rat carotid arteries and whether the contraction involves phosphoinositide 3-kinase (PI3K)/3-phosphoinositide-dependent protein kinase 1 (PDK1) signaling, an insulin-mediated signaling pathway. In rat carotid arteries organ-cultured with insulin (for 24 h), (1) the contractile responses to 5-HT were significantly greater (vs. vehicle), (2) the insulin-induced enhancement of 5-HT-induced contractions was largely suppressed by inhibitors of the insulin receptor (IR) (GSK1838705A), PI3K (LY294002), and PDK1 (GSK2334470), and (3) the levels of phosphorylated forms of both PDK1 and myosin phosphatase target subunit 1 (MYPT1) were greater upon 5-HT stimulation. In addition, in rat carotid arteries organ-cultured with an activator of PDK1 (PS48), the 5-HT-induced contraction was greater, and this was suppressed by PDK1 inhibition but not PI3K inhibition. In addition, MYPT1 and PDK1 phosphorylation upon 5-HT stimulation was enhanced (vs. vehicle). These results suggest that high insulin levels amplify 5-HT-induced contraction. Moreover, the present results indicated the direct linkage between IR/PI3K/PDK1 activation and 5-HT-induced contraction in rat carotid arteries for the first time.

Entities:  

Keywords:  Insulin receptor; Myosin phosphatase target subunit 1; Phosphoinositide 3-kinase; Phosphoinositide-dependent kinase 1; Vasoconstriction

Mesh:

Substances:

Year:  2015        PMID: 26577585     DOI: 10.1007/s00424-015-1759-4

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  70 in total

1.  Discovery of PDK1, one of the missing links in insulin signal transduction. Colworth Medal Lecture.

Authors:  D R Alessi
Journal:  Biochem Soc Trans       Date:  2001-05       Impact factor: 5.407

Review 2.  A new molecular target of insulin action: regulating the pivotal PDK1.

Authors:  K L Wick; F Liu
Journal:  Curr Drug Targets Immune Endocr Metabol Disord       Date:  2001-11

Review 3.  Organ culture as a useful method for studying the biology of blood vessels and other smooth muscle tissues.

Authors:  Hiroshi Ozaki; Hideaki Karaki
Journal:  Jpn J Pharmacol       Date:  2002-06

4.  Structure and allosteric effects of low-molecular-weight activators on the protein kinase PDK1.

Authors:  Valerie Hindie; Adriana Stroba; Hua Zhang; Laura A Lopez-Garcia; Leila Idrissova; Stefan Zeuzem; Daniel Hirschberg; Francis Schaeffer; Thomas J D Jørgensen; Matthias Engel; Pedro M Alzari; Ricardo M Biondi
Journal:  Nat Chem Biol       Date:  2009-08-30       Impact factor: 15.040

Review 5.  Mechanisms of diabetic complications.

Authors:  Josephine M Forbes; Mark E Cooper
Journal:  Physiol Rev       Date:  2013-01       Impact factor: 37.312

6.  Possible involvement of IGF-1 receptor and IGF-binding protein in insulin-induced enhancement of noradrenaline response in diabetic rat aorta.

Authors:  Tsuneo Kobayashi; Akihito Kaneda; Katsuo Kamata
Journal:  Br J Pharmacol       Date:  2003-08-26       Impact factor: 8.739

7.  GSK1838705A inhibits the insulin-like growth factor-1 receptor and anaplastic lymphoma kinase and shows antitumor activity in experimental models of human cancers.

Authors:  Peter Sabbatini; Susan Korenchuk; Jason L Rowand; Arthur Groy; Qi Liu; Dominic Leperi; Charity Atkins; Melissa Dumble; Jingsong Yang; Kelly Anderson; Ryan G Kruger; Richard R Gontarek; Kenneth R Maksimchuk; Sapna Suravajjala; Russell R Lapierre; J Brad Shotwell; Joseph W Wilson; Stanley D Chamberlain; Sridhar K Rabindran; Rakesh Kumar
Journal:  Mol Cancer Ther       Date:  2009-10       Impact factor: 6.261

Review 8.  Cardiovascular actions of insulin.

Authors:  Ranganath Muniyappa; Monica Montagnani; Kwang Kon Koh; Michael J Quon
Journal:  Endocr Rev       Date:  2007-05-24       Impact factor: 19.871

9.  Characterization of GSK2334470, a novel and highly specific inhibitor of PDK1.

Authors:  Ayaz Najafov; Eeva M Sommer; Jeffrey M Axten; M Phillip Deyoung; Dario R Alessi
Journal:  Biochem J       Date:  2011-01-15       Impact factor: 3.857

Review 10.  Mineralocorticoid receptor-mediated vascular insulin resistance: an early contributor to diabetes-related vascular disease?

Authors:  Shawn B Bender; Adam P McGraw; Iris Z Jaffe; James R Sowers
Journal:  Diabetes       Date:  2013-02       Impact factor: 9.461

View more
  7 in total

1.  Glucose and angiotensin II-derived endothelial extracellular vesicles regulate endothelial dysfunction via ERK1/2 activation.

Authors:  Kumiko Taguchi; Mari Hida; Haruka Narimatsu; Takayuki Matsumoto; Tsuneo Kobayashi
Journal:  Pflugers Arch       Date:  2016-12-14       Impact factor: 3.657

2.  Multiple activation mechanisms of serotonin-mediated contraction in the carotid arteries obtained from spontaneously hypertensive rats.

Authors:  Shun Watanabe; Takayuki Matsumoto; Makoto Ando; Tsuyuki Adachi; Shota Kobayashi; Maika Iguchi; Miki Takeuchi; Kumiko Taguchi; Tsuneo Kobayashi
Journal:  Pflugers Arch       Date:  2016-05-12       Impact factor: 3.657

3.  Amplification of the COX/TXS/TP receptor pathway enhances uridine diphosphate-induced contraction by advanced glycation end products in rat carotid arteries.

Authors:  Takayuki Matsumoto; Mihoka Kojima; Keisuke Takayanagi; Tomoki Katome; Kumiko Taguchi; Tsuneo Kobayashi
Journal:  Pflugers Arch       Date:  2019-11-18       Impact factor: 3.657

4.  Decreased contraction induced by endothelium-derived contracting factor in prolonged treatment of rat renal artery with endoplasmic reticulum stress inducer.

Authors:  Makoto Ando; Takayuki Matsumoto; Kumiko Taguchi; Tsuneo Kobayashi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-05-04       Impact factor: 3.000

5.  Mechanisms underlying suppression of noradrenaline-induced contraction by prolonged treatment with advanced glycation end-products in organ-cultured rat carotid artery.

Authors:  Takayuki Matsumoto; Keisuke Takayanagi; Mihoka Kojima; Kumiko Taguchi; Tsuneo Kobayashi
Journal:  Pflugers Arch       Date:  2020-01-18       Impact factor: 3.657

Review 6.  Serotonin and Its Receptor as a New Antioxidant Therapeutic Target for Diabetic Kidney Disease.

Authors:  Yu Yang; Hui Huang; Zheng Xu; Jun-Kai Duan
Journal:  J Diabetes Res       Date:  2017-08-08       Impact factor: 4.011

7.  Up-regulation of FoxO1 contributes to adverse vascular remodelling in type 1 diabetic rats.

Authors:  Jingjin Liu; Xiang Xie; Dan Yan; Yongshun Wang; Hongbin Yuan; Yin Cai; Jierong Luo; Aimin Xu; Yu Huang; Chi Wai Cheung; Michael G Irwin; Zhengyuan Xia
Journal:  J Cell Mol Med       Date:  2020-10-27       Impact factor: 5.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.